Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 3/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.51 |
| ▸ | EDNRA | P25101 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.48 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dansylsarcosine SCHEMBL30586115 | 1.00 | L3MBTL1 (0.61) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| Dansylsarcosine SCHEMBL23850005 | 0.89 | CYP1A2 (0.50) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| Dansylsarcosine SCHEMBL30745135 | 0.89 | CYP1A2 (0.50) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL15627403 | 0.84 | CYP1A2 (0.56) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| Dansylsarcosine SCHEMBL5500548 | 0.84 | L3MBTL1 (0.45) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL11888757 | 0.82 | KEAP1 (0.66) | L3MBTL1CA2KEAP1NFE2L2PRSS1 | |
| SCHEMBL26005791 | 0.82 | CYP1A2 (0.77) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL12964231 | 0.81 | CYP1A2 (0.62) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL14178940 | 0.81 | CYP1A2 (0.59) | L3MBTL1CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL39163 | 0.80 | ALDH1A1 (0.48) | L3MBTL1KEAP1NFE2L2ALDH1A1MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3748 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3612842-B1 | METHODS FOR DETERMINING THE RELATIVE BINDING CAPACITY OF ALBUMIN | FRAUNHOFER GES FORSCHUNG (DE) | 2025-11-26 | — | — | EP | claimed |
| CN-119993473-A | System and method for predicting long-term prognosis of liver disease patient | 上海交通大学医学院附属瑞金医院 | 2025-05-13 | — | — | CN | claimed |
| EP-3884280-B1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | INST NAT SANTE RECH MED (FR) | 2024-01-17 | — | — | EP | claimed |
| US-20220018852-A1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LIMOGES (FR) | 2022-01-20 | — | — | US | claimed |
| EP-3884280-A1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2021-09-29 | — | — | EP | claimed |
| CN-101175766-B | Albumin solution | ALBUTEC GMBH | 2015-04-29 | — | — | CN | claimed |
| US-8476081-B2 | Assay for evaluating affinity and specificity of ligand-albumin binding | JANSSEN PHARMACEUTICA NV (BE) | 2013-07-02 | — | — | US | claimed |
| US-20110124120-A1 | ASSAY FOR EVALUATING AFFINITY AND SPECIFICITY OF LIGAND-ALBUMIN BINDING | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-05-26 | — | — | US | claimed |
| US-20100240602-A1 | METHODS AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | BURKE THOMAS G | 2010-09-23 | — | — | US | claimed |
| EP-1315973-B1 | INDIRECT METHOD FOR THE QUANTITATIVE ANALYSIS OF THE BINDING CAPACITY PRESENT IN AN AQUEOUS PROTEIN SOLUTION | GAMBRO LUNDIA AB (SE) | 2009-07-29 | — | — | EP | claimed |
| JP-2003501487-A | — | — | 2003-01-14 | — | — | JP | claimed |
| JP-2002544523-A | — | — | 2002-12-24 | — | — | JP | claimed |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | NEW CENTURY PHARMACEUTICALS, INC. | 2002-12-19 | — | — | US | claimed |
| WO-2002074246-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1185305-A1 | LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-13 | — | — | EP | claimed |
| EP-1180244-A2 | HIGH TROUGHPUT ASSAY SYSTEMS AND METHODS | Caliper Technologies Corporation (US) | 2002-02-20 | — | — | EP | claimed |
| WO-2000076554-A1 | LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2000-12-21 | — | — | WO | claimed |
| WO-2000070353-A2 | HIGH THROUGHPUT ASSAY SYSTEMS AND METHODS | CALIPER TECHNOLOGIES CORP. (US) | 2000-11-23 | — | — | WO | claimed |
| US-5541633-A | Ink jet printing of concealed images on carbonless paper | XEROX CORPORATION (US) | 1996-07-30 | — | — | US | claimed |
| US-5286286-A | Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | claimed |